BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 12, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 26, 2010
View Archived Issues
Anti-Addiction Drug Breaks Dopamine's Vicious Cycle
Read More
NewCo News: Radical Therapeutix Works to Protect Precious Heart Tissue
Read More
Stock Movers
Read More
Other News To Note
Read More
Financings Roundup
Read More
Somaxon Secures Partner P&G to Co-Promote Insomnia Drug
San Diego-based Somaxon Pharmaceuticals Inc. plans to launch its Silenor insomnia drug in September with the help of Proctor & Gamble Co., which will co-promote the prescription drug in the U.S. (BioWorld Today)
Read More
Neuralstem Files Spinal Cord IND Amid Stem Cell Hubbub
Read More
